Pink Viagra sales tank
A few weeks ago “pink Viagra”, more properly known as Addyi, got a green light from the FDA. The drug purports to treat “hypoactive sexual desire disorder” in women. The day after the approval, Sprout Pharmaceuticals, a small company with the patent, was sold for US$1 billion in cash to Valeant Pharmaceuticals International. Valeant obviously thought it had a winner.
It turns out that it has backed the wrong horse. In the first few weeks, only 227 prescriptions have been filled. “I thought there was going to be this huge onslaught,” the director of the Women’s Health Clinic at the Mayo Clinic told Bloomberg Business.
Addyi has a lot of drawbacks; it has potentially deadly side effects, women can’t drink alcohol while using it; it costs US$780 a month; and it must be taken daily. But the biggest problem might be that Valeant believed Sprout’s canny public relations campaign which promoted sex as “a basic human right” and one of the FDA’s “priority areas of unmet medical need”. Perhaps women are more interested in commitment than a Viagra they can call their own.
Michael Cook
Only 227 prescriptions have been filled.
1447673820
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
After inserting abortion in France’s constitution, Macron tackles euthanasia
French president Emmanuel Macron has announced that he will back legislation to legalise "aid in dying" for terminally-ill adults. A report last...
Scientists move step closer to making IVF eggs from skin cells
Researchers at Oregon Health & Science University have developed a promising technique for creating artificial eggs. In the journal Science Advances they described...
The long march begins: assisted dying in Ireland
Ireland probably has the most explicitly Christian constitution in the world. Its preamble begins: “In the Name of the Most Holy Trinity,...
Licence of London fertility clinic suspended after losing embryos
After a decision by the Supreme Court of Alabama in a case about the destruction of embryos sent ripples around...
Health authorities in England block puberty blockers
British children with gender dysphoria will no longer be given puberty blockers, says the UK government health authority, the national health...
California could liberalise conditions for assisted suicide
California’s End of Life Option Act, which regulates assisted suicide, passed in 2015 and became operative on June 9, 2016. Like...